Eli Lilly and Company (BMV:LLY)
17,234
+449 (2.67%)
At close: Apr 25, 2025, 2:00 PM CST
Eli Lilly and Company Revenue
In the year 2024, Eli Lilly and Company had annual revenue of $45.04B USD with 32.00% growth. Eli Lilly and Company had revenue of $13.53B in the quarter ending December 31, 2024, with 44.68% growth.
Revenue
$45.04B
Revenue Growth
+32.00%
P/S Ratio
16.12
Revenue / Employee
$958.36K
Employees
47,000
Market Cap
15.13T MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition